Skip to main content
. 2016 Jan 4;8(1):2. doi: 10.3390/nu8010002

Table 1.

Demographic, anthropometric and clinical characteristics of the population.

Variables Overweight/Obese (OO) (n = 80) Metabolic Syndrome (MS) (n = 58) T2 Diabetes (T2DM) (n = 34) P ANOVA p Post-Hoc Analysis
Females (%) 31.3 34.5 35.3 0.63 /
Age (years) 56 ± 10 58 ± 9 62 ± 10 0.016 OO vs. T2DM 0.004
Weight (Kg) 83 ± 17 87 ± 21 85 ± 20 0.505 /
BMI (Kg/m2) 33 ± 6 34 ± 7 34 ± 6 0.514 /
WC (cm) 102 ± 14 106 ± 15 108 ± 13 0.120 /
HC (cm) 109 ± 15 110 ± 12 110 ± 11 0.905 /
SBP (mmHg) 122 ± 11 133 ± 15 130 ± 13 <0.001 OO vs. MS < 0.001
OO vs. T2DM 0.003
DBP (mmHg) 78 ± 8 80 ± 11 77 ± 9 0.161 /
Glucose-mg/dL (mmol/L) 91 ± 9 (5.06 ± 0.5) 100 ± 10 (5.56 ± 0.5) 130 ± 45 (7.22 ± 2.5) <0.001 OO vs. MS 0.019
OO vs. T2DM < 0.001
MS vs. T2DM < 0.001
Insulin-mU/L (pmol/L) 16 ± 8 (114.7 ± 57) 23 ± 20 (164.9 ± 143) 35 ± 26 (250.9 ± 186) 0.039 OO vs. T2D 0.012
HOMA-IR 3.7 ± 2 6 ± 5 12 ± 11 0.004 OO vs. T2DM 0.001
MS vs. T2DM 0.017
TotCholesterol-mg/dL (mmol/L) 199 ± 38 (5.14 ± 0.98) 213 ± 42 (5.5 ± 1.09) 195 ± 47 (5.04 ± 1.2) 0.055 OO vs. MS 0.042
MS vs. T2DM 0.037
HDL (mmol/L) 1.52 ± 0.41 1.16 ± 0.36 1.37 ± 0.44 <0.001 OO vs. MS < 0.001
OO vs. T2DM 0.017
MS vs. T2DM 0.046
LDL (mmol/L) 3.18 ± 0.83 3.39 ± 0.96 2.97 ± 1.06 0.141 /
Triglycerides (mmol/L) 91 ± 28 (1.03 ± 0.32) 201 ± 81 (2.27 ± 0.91) 151 ± 85 (1.70 ± 0.96) <0.001 OO vs. MS < 0.001
OO vs. T2D < 0.001
MS vs. T2D < 0.001
Prevalence
Hypertension (%) 12 26 52 0.001 /
Dyslipidemia (%) 19 29 30 0.129 /
Smokers (%) 38 46 24 0.390 /
Antidiabetic agents (%) 0 0 56 <0.001 /
Antihypertensive agents (%) 0 0 56 <0.001 /
Lipid lowering agents (%) 0 0 44 <0.001 /

Legend: BMI, body mass index; DBP, diastolic blood pressure; HC, hip circumferences; HDL, high density lipoprotein; HOMA IR, Homeostasis Model Assessment of Insulin Resistance; LDL, low density lipoprotein; SBP, systolic blood pressure; Tot Cholesterol, total cholesterol; WC, Waist circumferences.